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Abstract The last Crypto-Jews (Marranos) are the sur-
vivors of Spanish Jews who were persecuted in the late
fifteenth century, escaped to Portugal and were forced to
convert to save their lives. Isolated groups still exist in
mountainous areas such as Belmonte in the Beira-Baixa
province of Portugal. We report here the genetic study of
a highly consanguineous endogamic population of Crypto-
Jews of Belmonte affected with autosomal recessive re-
tinitis pigmentosa (RP). A genome-wide search for ho-
mozygosity allowed us to localize the disease gene to
chromosome 15q22-q24 (Zmax=2.95 at θ=0 at the
D15S131 locus). Interestingly, the photoreceptor cell-spe-
cific nuclear receptor (PNR) gene, the expression of
which is restricted to the outer nuclear layer of retinal
photoreceptor cells, was found to map to the YAC contig
encompassing the disease locus. A search for mutations
allowed us to ascribe the RP of Crypto-Jews of Belmonte
to a homozygous missense mutation in the PNR gene.
Preliminary haplotype studies support the view that this
mutation is relatively ancient but probably occurred after
the population settled in Belmonte.
Introduction
In the late fifteenth century, the golden age of Sephardic
Jewry in the Iberian peninsula came to an end at time of
the Spanish Inquisition in 1492, when Jews were offered
conversion or expulsion. Many chose to leave Spain but
others stayed behind. Some Jews escaped from Spain to
Portugal in 1492 only to be trapped later, in 1497, when
the expulsion was instituted there as well. Many were
forced to convert to save their lives. Large numbers of
middle class Jews outwardly took on Christianity to avoid
the laws, while secretly practicing Judaism despite the
danger of Inquisition punishment. Therefore, they were
often considered as faithless in their Christian conversion,
rousing old anti-Semitic prejudices and, thus, were called
“Marranos”, meaning “pigs” in the Castillan language of
the 15th century. Converted Jews never accepted this
name and referred to themselves as “Crypto-Jews”.
These Crypto-Jews still exist in isolated pockets on the
Iberian peninsula, in mountainous areas such as the
mountain town of Belmonte in the Beira-Baixa province
of Portugal (Fig.1). Their existence came to light in 1917
through the discoveries of Samuel Schwartz, a Polish-
Jewish mining engineer, who vainly sought for remnants
of the Belmonte synagogue of 1297. Five centuries after
the Inquisition, the last Crypto-Jewish community took a
fascinating look at the village of Belmonte, Portugal. Its
rites and prayers are an amalgam of Christianity and bits
of Judaism tenaciously preserved through the ages, a tra-
dition that bears the scars of history distorted by clandes-
tine practice and couched in symbols of fear. In order to
secretly preserve their residual Jewish practices over the
centuries, the Crypto-Jews of Belmonte were forced to
practice endogamy. In the absence of Rabbi, religious
books, synagogue or Hebraic education, the Jewish liturgy
was orally transmitted from one generation to the other,
essentially by females (Yerushalmi et al. 1992). The high
rate of parental consanguinity in this community led to the
occurrence of an autosomal recessive form of retinitis pig-
mentosa (RP; Fig.2). RP is a heterogeneous group of in-
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Fig.1 A Map of Portugal showing the mountainous village of Belmonte in the Beira-Baixa province. B Secret preparation of Passover
(Pessah): clandestine making of unleavened bread (Matza) in cellar
Fig.2 Pedigree of the Belmonte family. The solid and open symbols represent affected and unaffected individuals, respectively. Indi-
viduals included in this study are shown in bold
herited human diseases in which retinal degeneration leads
to visual loss and eventually to blindness. Many disease-
causing mutations have been shown to involve genes en-
coding rod outer segment proteins (for a review, see Dryja
and Li 1995) but many more RP genes have yet to be
identified.
Materials and methods
Patients
A highly consanguineous population affected with autosomal re-
cessive RP (Fig.2) was ascertained through the Ophthalmologic
Consultation of the Dos Capuchos Hospital of Lisboa. All family
members underwent general and ophthalmologic examinations.
Each patient’s blood was collected in Belmonte and brought back
to France for analysis.
Four markers containing short tracks of (CA)n repeats and
flanking each of the thirteen RP loci studied were chosen from the
Généthon Linkage Map (Dib et al. 1996) on the basis of their in-
formativity (not shown, available on request). On the other hand, a
genome-wide search for homozygosity was undertaken in nine RP
patients (Fig.4) with the 382 pairs of fluorescent oligonucleotides
of the Genescan Linkage Mapping Set, Version II (Perkin Elmer
Cetus) under conditions recommended by the manufacturer. Am-
plified fragments were electrophoresed and analyzed on an auto-
matic sequencer (ABI 377). The polymorphic markers have an av-
erage spacing of 10 cM throughout the genome. Linkage analyses
were performed using M-LINK and LINKMAP of the 5.1 version
of the Linkage program (Lathrop and Lalouel 1984; Lander and
Bolstein 1987).
Fluorescence in situ hybridization 
For fluorescence in situ hybridization (FISH), elongated chromo-
somes from a healthy donor were obtained from lymphocyte syn-
chronized culture. The YAC 960b6 was used as a probe to deter-
mine the chromosome localization of the photoreceptor cell-spe-
cific nuclear receptor (PNR) gene. The YAC DNA was amplified
by Alu-PCR reaction and labeled with FITC-dUTP (Roche) by
nick translation. Normal metaphase chromosomes were hybridized
using 10 ng/ml of labeled probe for 24 h and the signal was ana-
lyzed on an epifluorescent microscope (Leica) with the QFISH vy-
sis software. Ten mitoses were analyzed to determine the probe lo-
calization.
Mutation screening of SLC24A1
The ten exons encoding the retinal rod Na-Ca-K exchanger gene
(SLC24A1) were amplified and sequenced using specific primers
designed from the intronic sequences nearby the intron-exon junc-
tions (data not shown, available on request).
Mutation screening of PNR
The PNR gene (200 ng genomic DNA) of patient IV-9 (Fig.2) was
amplified in two overlapping fragments (F1: 2700 bp and F2: 4360
bp) with specific primers designed from the cDNA sequence (P1-
P2, P3-P4, respectively) in a buffer (15 µl) containing 50 mM Tris-
HCl (pH 9.2), 16 mM (NH4)2SO4, 2.25 mM MgCl2, 2% (v/v)
DMSO, 1% (v/v) Tween, 400 µM of each dNTP, 400 nM of each
primer and 1.5 U of Taq DNA-Pwo DNA polymerase (Expand
Template PCR System, Roche). After an initial denaturation for 
5 min at 94°C, denaturation was at 93°C for 10 s and annealing/ex-
tension were at 65°C for 3 min, for 30 cycles followed by a final
extension, for 7 min at 68°C.
Amplified products were loaded onto a 1% agarose gel, puri-
fied by phenol-chloroform extraction and recovered by ethanol
precipitation. Purified fragments were directly sequenced using
specific primers designed from the cDNA sequence: P1-P3, P5-P8
for fragment F1; and P3, P4, P9, P10 for fragment F2.
Oligonucleotide sequences (forward/reverse, 5’–3’) of the PNR
gene were as follows: P1 (5′-GCCAGGCTCAGCAACCCAGG-
3′); P2 (5′-GGCTTGAAGAGGACCAAGG-3′); P3 (5′-CCTG-
CTGGAAGAGGCGTGG-3′); P4 (5′-CACCTACGAGGAATTG-
CTGG-3′); P5 (5′-CCTGCAGGCACTTCTTCAGC-3′); P6 (5′-
CTTAGCACAGGTTTCAGCTG-3′); P7 (5′-CCTGCGGCCTGG-
ACAGCATC-3′); P8 (5′-GCCATGAAGAGTAGGCGAGC-3′);
P9 (5′-GGATCCTGAGCACGTAGAG-3′); P10 (5′-CTGGCTC-
AGCATCACTTGG-3′)
For screening the G1020A PNR mutation in the Crypto-Jews
and in the general population, genomic DNA (200 ng) of all pa-
tients and relatives, as well as 192 controls of various ethnic ori-
gins, was submitted to PCR amplification using 1 µM of primers
P2, P3 and α[33P]dCTP (0.07 µl, 10 mCi/ml; NEN) in an amplifi-
cation mixture (20 µl) containing 200 µM dNTPs and 0.5 U Taq
DNA polymerase (Life-Technologies). Amplified DNA (6 µl) was
mixed with an equal volume of formamide loading dye (95% 
formamide, 20 mM EDTA, 0.05% bromophenol blue, 0.05% xy-
lene cyanol), denatured for 10 min at 95°C, loaded onto a
polyacrylamide gel (30×40×0.04 cm MDE, TEBU) and elec-
trophoresed at room temperature for 14 h at 4 W. Gels were trans-
ferred onto 3 MM Whatman paper, dried and autoradiographed
with Kodak BIOMAX-MR films for 16–48 h.
Plasmid construction 
The VP-PNR construct was obtained by inserting the full length
human PNR cDNA (hPNR) into pVP-16 (Clontech). The GAL4-
PNR construct was obtained by inserting the hPNR ligand binding
domain (LBD) into pCMX-GAL4. The hPNR coding sequences
used above were obtained by PCR amplification from pMOS-
hPNR (Kobayashi et al. 1999). Primers used were: 5’ (5′-GCG-
AATTCATGGAGACCAGACCAAACGCTCTC-3′) and 3’ (5′-
GCGTCGACCTAGTTTTTGAACATATCACAAAG-3′) for VP-
PNR; 5’ (5′-AGCTGAATTCATGAACCAGGACGCCGTGCA-
3′) and 3’ (5′-GTAATACGACTCACTATAGGGC-3′) for GAL4-
PNR. To prepare PNR mutant constructs, VP-PNR was used as a
template for 12 cycles of PCR with the following primers : 5’ (5′-
CTATCTCTCGGTTCCAGGCATTGGCGGTG-3′) and 3’ (5′-CA-
CCGCCAATGCCTGGAACCGAGAGATAG-3′); the DNA was
digested with DpnI and transformed to select for positive colonies.
GAL4 mutants were derived from the VP-PNR R311Q construct.
The PNRE-tk-luc reporter was constructed by insertion of the fol-
lowing double-stranded oligonucleotide primer (5′-AAGTCA-
AAAGTCAACTAAAAGTCAAAAGTCA-3′) into tk-luc (Glass
et al. 1989). All constructs were confirmed by sequencing.
Transactivation assays
Human embryonic kidney 293T cells were used for transfection
assays in 24-well cluster tissue culture plates with Lipofectin
Reagent (Life Technologies). Transfection mixtures contained the
indicated concentrations of plasmid, 500 ng tk-luc reporter and 
5 ng pRL-CMV vector (Promega) as control for transfection effi-
ciency. For the mammalian two-hybrid assay (Forman et al. 1995),
transfection mixtures contained 100 ng GAL-fusion plasmids, 
100 ng VP-fusion plasmids, 500 ng MH100-tk-luc reporter plas-
mids and 5 ng of pRL-CMV vector (Promega). Cells were trans-
fected for 4 h, incubated for 36 h in DMEM containing 10% FBS
prior to harvesting and assaying for luciferase activity with the
Dual-Luciferase TM Reporter Assay System (Promega). The val-
ues were first measured for luciferase activity in relative light
units, then normalized against the beta-galactosidase used as an in-
ternal control for transfection activity. The interaction between the
wild-type PNR (VP and GAL) was taken as 100% and all other
values were calculated correspondingly. All experimental determi-
nations were performed in triplicate and repeated at least twice
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during independent experiments with variations of less than 10%.
Dating the founder mutation 
The G1020A mutation occurred in an ancestor haplotype that
could be reconstructed by comparing the distinct pedigree haplo-
types. For any generation number (g) elapsed since the occurrence
of the mutation (i.e., the earliest common ancestor), the probability
of observing the remaining original haplotype on one side of a mu-
tation in a given interval (t) can be directly calculated as (1-t)
(Blumberg and Evans 1998).The likelihood of any generation
number is computed following Bayes theorem by dividing each of
these probabilities by the sum of all probabilities (Hästbacka et al.
1992; Piccolo et al. 1996).
Results
Clinical features of RP
The clinical history of RP starts within the first decade
with night blindness, followed during the second and the
third decades by a slow concentric reduction of the visual
field. Visual acuity decreases around 40 years of age, but
the affected individuals are not completely blind even
when elderly. The fundus shows typical features of RP
i.e., pigment deposits in the peripheral retina, retinal pig-
ment epithelium (RPE) atrophy, and waxy pallor of the
optic nerve. The visual field measurement shows concen-
tric reduction leading to tubular visual field (Fig.3). The
electroretinogram is severely reduced in the first stages
and is not recordable at advanced stages. No associated
symptoms, such as deafness, obesity, mental retardation,
hypogonadism, renal failure or hexadactyly, were noted.
Primary mapping of the RP-causing gene
We first excluded the thirteen loci already known to ac-
count for autosomal recessive RP, i.e., RHO, PDE6B,
PDE6A, RLBP1, RP12, TULP1, CNGA1, ABCR, RPE65,
RP22, RP25, RP26, SAG (Genatlas: http://www.citi2.fr/
GENATLAS/welcome.html). Subsequently, a genome-wide
search for homozygosity was undertaken and a total of
382 polymorphic markers were tested in this pedigree. We
found evidence of homozygosity at the D15S131 locus in
all nine affected individuals. The shortest area of homozy-
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Fig.3 A Fundus of IV3. Note the typical aspect of retinitis pig-
mentosa with pigmentary spicules, very thin vessels and chorio-
retinal atrophy. B Tubular visual field of IV3
gosity is defined by the D15S983–D15S1026 interval, but
recombination events in an healthy woman (V4) sup-
ported placement of the disease gene in the 5.4 cM inter-
val defined by loci D15S1015 and D15S204 (Fig.4). The
maximal pairwise lod score was obtained at the D15S131
locus (Zmax=2.95 at θ=0). It is worth noting that, due to
the high level of consanguinity, and despite the number of
meioses, a relatively low score value was obtained. Fi-
nally, no other homozygous region was found using the
remaining markers tested.
Identification of the RP-causing gene
The SLC24A1 gene has been recently mapped to chromo-
some 15q22 between markers D15S125 and D15S216
(Tucker et al. 1998), an interval which overlaps the ge-
netic interval encompassing the RP locus. A search for
mutations was undertaken in our nine patients using direct
sequencing and no deleterious change was found in any of
the ten exons nor in any of the nine exon-intron bound-
aries of the gene allowing us to exclude the SLC24A1
gene.
Starting from the flanking markers, D15S1015 and
D15S204, seven YAC clones were ordered on chromo-
some 15q22-q24 using ESTs and STSs of the region (Fig.
5A). Interestingly, the PNR gene encoding the photore-
ceptor cell-specific nuclear receptor, localized on chromo-
some 15q24 (Kobayashi et al. 1999), was found to map to
YAC 960b6 (Fig.5A). Using the YAC 960b6 probe, FISH
unambiguously showed spots on chromosome 15q23 in
80% of R-banding metaphases, allowing us to refine the
previous physical mapping of the PNR gene from 15q24
to 15q23 (Fig.5B). We therefore regarded PNR as an at-
tractive candidate gene by both position and function. The
genomic structure of the PNR gene is unknown but the se-
quence of the human cDNA and the position of the introns
have been reported (GenBank accession no. AF121129).
The entire PNR gene was amplified in two overlapping
fragments using specific primers designed from the
cDNA sequence. A search for mutations was undertaken
for the nine available patients by direct sequencing. All
patients tested were found to carry a homozygous mis-
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Fig.4 Haplotype of the Belmonte family at the 15q22-q24 region
sense mutation in exon 6 at nucleotide 1020 (G1020A,
Fig.6). This mutation changed an arginine into a gluta-
mine in the protein (R311Q). This base change caused an
abnormal SSCP pattern of migration that segregated with
the disease in the entire pedigree and was absent in 192
controls of various ethnic origins.
Functional analyses
The region affected by the mutation is known to be in-
volved in dimerization of nuclear receptor members (for
review, see Mangelsdorf et al. 1995), and the formation of
homodimers by PNR is regarded as essential for its DNA
binding function (Kobayashi et al. 1999). By means of the
mammalian two-hybrid technique (Forman et al. 1995),
which utilizes chimeric receptors containing the yeast
Gal4 DNA binding domain and a nuclear receptor ligand
binding domain (LBD), we investigated how this single
nucleotide change in the PNR LBD affected its function.
The results clearly demonstrated that the R311Q mutation
hinders the ability of PNR to form stable dimers (Fig. 7B).
Interestingly, this mutation did not significantly alter the
in vitro DNA binding capacities (not shown) nor the abil-
ity of PNR to repress transcription through its DNA re-
sponse element upon overexpression in cultured cells
(Fig.7A).
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Fig.5 A YAC contig encompassing the gene responsible for RP
in the Belmonte population at the 15q22-q24 locus. B Refining of
PNR localization by FISH: the red signal corresponds to the hy-
bridization of the YAC 960b6 on the 15q23 band
Fig.6 Identification of a ho-
mozygous missense mutation,
G1020A, in exon 6 of the PNR
gene (C control, P patient)
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Mutation data
Computation suggested that the most likely number of
generations elapsed since the appearance of the mutation
averages 15 (95% confidence interval: 8–20, not shown).
Assuming that one generation lasts 25 years, this would
indicate that the G1020A mutation is ancient and occurred
between 200 and 500 years ago.
Discussion
Here we report on the mapping of a new RP gene to chro-
mosome 15q23 in a large pedigree of Portuguese Crypto-
Jews, the descendants of the Marranos who lived in Spain
and Portugal in the 15th century. Homozygosity mapping
and key recombinant events allowed us to reduce the crit-
ical interval to a region of 5 cM encompassing the PNR
gene and to eventually identify the disease-causing mis-
sense mutation in exon 6 of the gene. This genetic interval
overlaps the chromosomal region in which the fourth gene
responsible for Bardet-Biedl syndrome (BBS4) has been
mapped (Carmi et al. 1995; Bruford et al. 1997). Yet, af-
fected individuals of the Crypto-Jews population of Bel-
monte displayed no symptom of BBS, i.e., obesity, hy-
pogonadism, mental retardation, renal cysts or poly-
dactyly, raising the possibility of either two different RP
genes within the same chromosomal region or, alterna-
tively, various mutations in the same gene.
PNR is a member of a large family of ligand-depen-
dent transcription factors which transduce inter- and intra-
cellular lipophilic signals and contain DNA and ligand
binding domains (Kobayashi et al. 1999). In recent years,
many additional members of the family (the so-called or-
phan receptors) have been identified on the basis of these
structural features, which in turn has provided tools to
search for molecules acting as specific ligands in order to
unravel novel signaling pathways (Enmark and Gustafs-
son 1996; Blumberg and Evans 1998). In vertebrates, the
original member of this family, TLX, the homologue of
the Drosophila tailless gene, shows a restricted pattern 
of expression in the developing fore/midbrain neuro-
epithelium, retina, and nasal epithelium (Yu et al. 1994;
Monaghan et al. 1995).
Subsequently, by searching for other genes related to
TLX, the human PNR gene was identified. This gene is
specifically expressed in the outer nuclear layer of the
Fig.7 Functional analyses of wild-type and mutant PNR proteins.
A The G1020A mutation does not significantly affect the ability of
PNR to repress reporter gene transcription. The x-axis shows the
activity at two concentrations of PNR expression plasmid (0, 
100 ng, 200 ng) and the y-axis, the fold activity. The 100 value was
set at 0 ng as a standard from which other values were calculated.
Standard deviations (SD) for 100 and 200 ng were 2.8 and 1.5 for
the wild type and 1.8 and 2.4 for PNR-R311Q, respectively. B The
effect of the mutation on the ability of the PNR LBD to dimerize
was tested in the mammalian two-hybrid assay. Combinations of
constructs used are as indicated. GAL4 and VP16, which are
known to interact with high affinity, are shown as the positive con-
trol. The GAL4 and VP-PNR or VP16 and GAL-PNR, which
should not interact, are shown for background interaction. Note the
interaction between GAL-PNR wt with VP-PNR wt and the de-
crease in interaction with the mutant PNR. Starting from the left,
SD were: 6, 1.4, 1.6, 0 (value set at 100 against which other values
were calculated), 3.2, 2.1 and 1.5
retina photoreceptor cells. PNR is capable of binding to a
subset of TLX target sequences in vitro, suggesting that
they may be involved in the regulation of an overlapping
target gene network. Unlike TLX, however, which can
bind to and repress target gene transcription as a mono-
mer, PNR requires dimeric half-site sequences, and gel-
shift analyses have shown that it binds to DNA, most
likely as a homodimer (Kobayashi et al. 1999). The re-
sults of our analyses of the mutation in the PNR gene in-
dicate that the amino acid substitution in the LBD signifi-
cantly hampers its ability to dimerize. However, in in vitro
DNA binding and in transient transfection assays, the mu-
tated PNR retained its ability to bind DNA, and to repress
transcription. This likely reflects the result of the high lev-
els of protein obtained from overexpression in the assays.
In an in vivo situation, the amount of PNR may be limit-
ing, and thus even slight impairments in function would
result in a disease phenotype.
The identification of such a photoreceptor-restricted
nuclear receptor implies its possible involvement in a sig-
naling pathway regulating photoreceptor differentiation
and/or maintenance, which may be mediated by lipophilic
molecules acting as PNR ligands. Indeed, PNR is believed
to play a major role in the photoreceptor cell-specific
transcription cascade by suppressing genes whose expres-
sion is refractory to photoreceptor function (Kobayashi et
al. 1999). Chen et al. (1999) recently reported the identifi-
cation of a splice variant of human PNR, which they
termed RNR, as it is expressed in the retinal pigment ep-
ithelium and Müller glial cells of the adult. They further
showed the possible involvement of PNR in the regulation
of the cellular retinaldehyde-binding protein (CRALBP),
an important component of the visual cycle. Taken to-
gether, these findings strongly support the involvement of
PNR in retinal diseases.
In fact, Haider et al. (2000) recently reported on muta-
tions in the PNR gene of patients affected with the so-
called enhanced S cone syndrome. This syndrome is not
clinically defined as the degree of clinical heterogeneity is
extremely large. Indeed, patients affected with the en-
hanced S-cone syndrome can be classified either with
Goldmann-Favre syndrome or with other variable features
including macular scarring, yellow flecks in the retina,
pigmentary retinopathy, peripheral retinoschisis and cata-
racts. On the other hand, this syndrome is only defined by
a severe dysfunction of S cones compared to the function
of L/M cones. This feature can only be detected by a par-
ticular electroretinographic measurement, i.e., S cone test-
ing. Surprisingly, among the 12 different mutations iden-
tified in the ESCS cohort of patients, the R311Q amino
acid change, identified in 13/29 unrelated patients (44.8%),
represents the most frequent mutation. It would be very
useful to know the exact phenotype of each of these 
13 patients, as well as the phenotype of patients harboring
different mutations in the PNR gene, in order to search for
genotype-phenotype correlations. Most interestingly, very
recently a deletion in the murine PNR gene has been iden-
tified in the rd7 mouse. The rd7 mice display clinical
signs of retinal degeneration from 12 months of age and
mottled retinal pigment is observed from 16 months. It is
worth noting that ERG measured between age 1–5 months
were strictly normal. ERG measurement only showed al-
terations from age 16 months. At this stage, these electri-
cal alterations were associated with attenuated reduction
of the caliber of the retinal vessels and mottled retinal pig-
ment indicating retinal degeneration, but no cystic change
in the foveal region or vitreous degeneration was noted.
The very late phenotype of the rd7 mouse is quite identi-
cal to the very late RP affecting the Crypto-Jews of Bel-
monte.
It would be interesting to perform S cone testing in our
RP patients but the Belmonte population is, for obvious
historical reasons, extremely closed and it has been ex-
tremely difficult to collect blood samples in only some of
all affected patients and relatives in order to perform this
work.
Finally, ongoing haplotype studies, as well as Bayesian
calculations (Hästbacka et al. 1992; Piccolo et al. 1996),
suggest that this mutation probably occurred 200–500
years ago, i.e., after this population of Crypto-Jews settled
in Belmonte.
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